Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 18, 2007 - Issue 3
Submit an article Journal homepage
433
Views
50
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis

Alan B. Fleischer Jr Wake Forest University, Winston‐Salem, NC, USACorrespondence[email protected]
,
William Abramovits Dermatology Treatment and Research Center, Dallas, TX, USA
,
Debra Breneman University of Cincinnati, Cincinnati, OH, USA
&
Eileen Jaracz Astellas Pharma US, Inc., Deerfield, IL, USA
Pages 151-157 | Received 23 Jan 2007, Accepted 12 Feb 2007, Published online: 12 Jul 2009

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ashraf M. Reda, Ayman Elgendi, Ahmed Ismail Ebraheem, Mohammed S. Aldraibi, Mohammed Saleh Qari, Magdy Mohammad R. Abdulghani & Thomas Luger. (2019) A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas. Journal of Dermatological Treatment 30:4, pages 366-373.
Read now
John Berth-Jones, Ian Pollock, Ross M. R. Hearn, Sue Lewis-Jones, Mark Goodfield, Christopher E. M. Griffiths, Ram Gulati, Pamela McHenry, Anthony Abdullah, Jennifer Ott, Andrew Wright, Benjamin Walker, Michael T. Stevens & Alan M. Edwards. (2015) A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children. Journal of Dermatological Treatment 26:3, pages 291-296.
Read now
Sakari Reitamo & Anita Remitz. (2014) An update on current pharmacotherapy options in atopic dermatitis. Expert Opinion on Pharmacotherapy 15:11, pages 1517-1524.
Read now
Masutaka Furue & Satoshi Takeuchi. (2009) Topical tacrolimus as treatment of atopic dermatitis. Clinical, Cosmetic and Investigational Dermatology 2, pages 161-166.
Read now

Articles from other publishers (46)

Rajlaxmi Deolekar, Vaibhav J. Gajbe, Bilal Sufi & Vivek K. Gohane. (2023) Review on Atopic Dermatitis. International Journal of Advanced Research in Science, Communication and Technology, pages 249-257.
Crossref
Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu & Dawn M.R. Davis. (2023) Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology 89:1, pages e1-e20.
Crossref
Youna Rodriguez-Le Roy, Anne-Sophie Ficheux, Laurent Misery & Emilie Brenaut. (2022) Efficacy of topical and systemic treatments for atopic dermatitis on pruritus: A systematic literature review and meta-analysis. Frontiers in Medicine 9.
Crossref
Deepti DwivediShubham PandeyShafaque AsifVineet AwasthiGurjeet KaurNimisha Nimisha. (2021) Investigating the potential of Quercetin enthused nano lipoidal system for the management of dermatitis. Research Journal of Pharmacy and Technology, pages 6516-6526.
Crossref
Golnaz Shams, Amirhossein Nayeri Rad, Mehdi Safdarian, Annahita Rezaie, Neda Bavarsad & Mohammadreza Abbaspour. (2021) Self-microemulsification-assisted incorporation of tacrolimus into hydrophilic nanofibers for facilitated treatment of 2,4-dinitrochlorobenzene induced atopic dermatitis like lesions. Journal of Drug Delivery Science and Technology 62, pages 102326.
Crossref
Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily B. Wong, Reena N. Rupani, Dario Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan & Alan Menter. (2021) Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology 84:2, pages 432-470.
Crossref
O.N. Zainullina, Z.R. Khismatullina & D.V. Pechkurov. (2021) Effectiveness evaluation of the proactive maintenance therapy of atopic dermatitis in children using optical coherence tomography and skin ultrasound. Klinicheskaya dermatologiya i venerologiya 20:2, pages 59.
Crossref
Suresh Kumar Sahu, Rakesh Raj, Pooja Mongia Raj & Ram Alpana. (2020) Topical Lipid Based Drug Delivery Systems for Skin Diseases: A Review. Current Drug Therapy 15:4, pages 283-298.
Crossref
Sam Hanna, Catherine Zip & Neil H. Shear. (2019) What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?. Journal of Cutaneous Medicine and Surgery 23:4_suppl, pages 19S-26S.
Crossref
Chih-ho Hong, Melinda Gooderham & Robert Bissonnette. (2019) Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 23:4_suppl, pages 5S-10S.
Crossref
Zoe D. Draelos, Steven R. Feldman, Brian Berman, Melissa Olivadoti, Debra Sierka, Anna M. Tallman, Michael A. Zielinski, William C. Ports & Sheryl Baldwin. (2019) Tolerability of Topical Treatments for Atopic Dermatitis. Dermatology and Therapy 9:1, pages 71-102.
Crossref
A. Remitz, O. De Pità, A. Mota, E. Serra-Baldrich, E. Vakirlis & A. Kapp. (2018) Position statement: topical calcineurin inhibitors in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 32:12, pages 2074-2082.
Crossref
Gurbir Dhadwal, Lorne Albrecht, Robert Gniadecki, Yves Poulin, Jensen Yeung, Chih-ho Hong & Melinda J. Gooderham. (2018) Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 22:1_suppl, pages 21S-29S.
Crossref
Mamitaro Ohtsuki, Hiroshi Morimoto & Hidemi Nakagawa. (2018) Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits. The Journal of Dermatology 45:8, pages 936-942.
Crossref
Takeshi Nakahara, Hiroshi Morimoto, Naofumi Murakami & Masutaka Furue. (2018) Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatric Allergy and Immunology 29:3, pages 233-238.
Crossref
Jeremy Udkoff, Andrea Waldman, Jusleen Ahluwalia, Jenna Borok & Lawrence F. Eichenfield. (2017) Current and emerging topical therapies for atopic dermatitis. Clinics in Dermatology 35:4, pages 375-382.
Crossref
Judith Günther & Uwe Fricke. 2017. Arzneiverordnungs-Report 2017. Arzneiverordnungs-Report 2017 431 476 .
Judith Günther & Uwe Fricke. 2016. Arzneiverordnungs-Report 2016. Arzneiverordnungs-Report 2016 427 470 .
Jade Cury Martins, Ciro Martins, Valeria Aoki, Aecio FT Gois, Henrique A Ishii & Edina MK da Silva. (2015) Topical tacrolimus for atopic dermatitis. Cochrane Database of Systematic Reviews.
Crossref
Hye One KimYoon Seok YangHyun Chang KoGyung Moon KimSang Hyun ChoYoung Joon SeoSang Wook SonJong Rok LeeJoong Sun LeeSung Eun ChangJae We CheChun Wook Park. (2015) Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment. Annals of Dermatology 27:5, pages 523.
Crossref
Xia Huang & Bo Xu. (2015) Efficacy and Safety of Tacrolimus versus Pimecrolimus for the Treatment of Atopic Dermatitis in Children: A Network Meta-Analysis. Dermatology 231:1, pages 41-49.
Crossref
Judith Günther & Uwe Fricke. 2015. Arzneiverordnungs-Report 2015. Arzneiverordnungs-Report 2015 589 659 .
Lawrence F. Eichenfield, Wynnis L. Tom, Timothy G. Berger, Alfons Krol, Amy S. Paller, Kathryn Schwarzenberger, James N. Bergman, Sarah L. Chamlin, David E. Cohen, Kevin D. Cooper, Kelly M. Cordoro, Dawn M. Davis, Steven R. Feldman, Jon M. Hanifin, David J. Margolis, Robert A. Silverman, Eric L. Simpson, Hywel C. Williams, Craig A. Elmets, Julie Block, Christopher G. Harrod, Wendy Smith Begolka & Robert Sidbury. (2014) Guidelines of care for the management of atopic dermatitis. Journal of the American Academy of Dermatology 71:1, pages 116-132.
Crossref
Uwe Fricke. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013 521 585 .
E S Fedenko, T M Filimonova, O G Elisyutina, O V Shtyrbul & D D Niyazov. (2012) Pathogenetic substantiation of an integrated approach to topical therapy of atopic dermatitis. Russian Journal of Allergy 9:4, pages 50-55.
Crossref
Helen NANKERVIS. (2012) Correspondence in relation to “Meta‐analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis”. The Journal of Dermatology 39:12, pages 1111-1112.
Crossref
Zhi Qiang YIN, Wei Ming ZHANG, Guo Xin SONG & Dan LUO. (2012) Retracted: Meta‐analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis . The Journal of Dermatology 39:6, pages 520-526.
Crossref
Hillary C. Frankel & Abrar A. Qureshi. (2012) Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis. American Journal of Clinical Dermatology 13:2, pages 113-123.
Crossref
R. Bissonnette, Y. Poulin, Y. Zhou, J. Tan, H.C. Hong, J. Webster, W. Ip, L. Tang & M. Lyle. (2012) Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial. British Journal of Dermatology 166:4, pages 853-860.
Crossref
Guiling Li, Chao Fan, Xinru Li, Yating Fan, Xiaoning Wang, Mei Li & Yan Liu. (2012) Preparation and In Vitro Evaluation of Tacrolimus-Loaded Ethosomes . The Scientific World Journal 2012, pages 1-6.
Crossref
Ulrich Schwabe & Dieter PaffrathUwe Fricke. 2012. Arzneiverordnungs-Report 2012. Arzneiverordnungs-Report 2012 533 595 .
Zhiqiang Yin, Jiali Xu & Dan Luo. (2011) Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis. Journal of Biomedical Research 25:6, pages 385-391.
Crossref
S A Ochelenko, K N Monakhov, S A Ochelenko & K N Monakhov. (2011) ТHE EFFICIENCY AND SAFETY OF CALCINEURIN INHIBITORS (TACROLIMUS) IN ATOPIC DERMATITIS AND OTHER DERMATOLOGICAL DISEASES. Russian Journal of Allergy 8:2, pages 89-95.
Crossref
Alexandra S.B. Goebel, Reinhard H.H. Neubert & Johannes Wohlrab. (2011) Dermal targeting of tacrolimus using colloidal carrier systems. International Journal of Pharmaceutics 404:1-2, pages 159-168.
Crossref
A Katsarou & MC Armenaka. (2011) Atopic dermatitis in older patients: particular points. Journal of the European Academy of Dermatology and Venereology 25:1, pages 12-18.
Crossref
Uwe Fricke. 2011. Arzneiverordnungs-Report 2011. Arzneiverordnungs-Report 2011 529 590 .
A A KUBANOVA, D V PROSHUTINSKAYA, L V TEKUCHEVA & I N AVDIYENKO. (2010) Integral approach to the external therapy of atopic dermatitis. Vestnik dermatologii i venerologii 86:1, pages 20-26.
Crossref
Uwe Fricke. 2010. Arzneiverordnungs-Report 2010. Arzneiverordnungs-Report 2010 511 572 .
J. Schauber, P. Weisenseel & T. Ruzicka. (2009) Topical treatment of perianal eczema with tacrolimus 0·1%. British Journal of Dermatology 161:6, pages 1384-1386.
Crossref
Alexandra S. B. Goebel, Johannes Wohlrab & Reinhard H. H. Neubert. (2009) Quantification of Tacrolimus in Human Skin Samples and Ointment by LC-MS. Chromatographia 70:3-4, pages 581-584.
Crossref
Bethany A. Cook & Erin M. Warshaw. (2009) Role of Topical Calcineurin Inhibitors in the Treatment of Seborrheic Dermatitis. American Journal of Clinical Dermatology 10:2, pages 103-118.
Crossref
Uwe Fricke. 2009. Arzneiverordnungs-Report 2009. Arzneiverordnungs-Report 2009 483 544 .
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:5, pages 489-497.
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:3, pages 276-285.
Crossref
F.J. Ortiz de Frutos. (2008) Dermatitis atópica y tacrolimus en adultos. Actas Dermo-Sifiliográficas 99, pages 8-13.
Crossref
Uwe Fricke. 2008. Arzneiverordnungs-Report 2008. Arzneiverordnungs-Report 2008 489 550 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.